Literature DB >> 35747199

Associating factors of suicide and repetition following self-harm: A systematic review and meta-analysis of longitudinal studies.

Bao-Peng Liu1,2, Cun-Xian Jia1,2, Ping Qin3, Ying-Ying Zhang1,2, Yao-Kun Yu1,2, Xiao Luo1,2, Shi-Xue Li4.   

Abstract

Background: Longitudinal evidence for sociodemographic and clinic factors deviating risk for suicide and repetition following SH (self-harm) varied greatly.
Methods: A comprehensive search of PubMed, Web of Science, EMBASE, and PsycINFO was conducted from January 1st, 2010 to April 5th, 2022. Longitudinal studies focusing on examining associating factors for suicide and repetition following SH were included. PROSPERO registration CRD42021248695. Findings: The present meta-analysis synthesized data from 62 studies published from Jan. 1st, 2010. The associating factors of SH repetition included female gender (RR, 95%CI: 1.11, 1.04-1.18, I2=82.8%), the elderly (compared with adolescents and young adults, RR, 95%CI: 0.67, 0.52-0.87, I2=86.3%), multiple episodes of SH (RR, 95%CI: 1.97, 1.51-2.57, I2=94.3%), diagnosis (RR, 95%CI: 1.60, 1.27-2.02, I2=92.7%) and treatment (RR, 95%CI: 1.59, 1.40-1.80, I2=93.3%) of psychiatric disorder. Male gender (RR, 95%CI: 2.03, 1.80-2.28, I2=83.8%), middle-aged adults (compared with adolescents and young adults, RR, 95%CI: 2.40, 1.87-3.08, I2=74.4%), the elderly (compared with adolescents and young adults, RR, 95%CI: 4.38, 2.98-6.44, I2=76.8%), physical illness (RR, 95%CI: 1.95, 1.56-2.43, I2=0), multiple episodes of SH (RR, 95%CI: 2.02, 1.58-2.58, I2=87.4%), diagnosis (RR, 95%CI: 2.13, 1.67-2.71, I2=90.9%) and treatment (RR, 95%CI: 1.36, 1.16-1.58, I2=58.6%) of psychiatric disorder were associated with increased risk of suicide following SH. Interpretation: Due to the substantial heterogeneity for clinic factors of suicide and repetition following SH, these results need to be interpreted with caution. Clinics should pay more attention to the cases with SH repetition, especially with poor physical and psychiatric conditions. Funding: This work was supported by National Natural Science Foundation of China (NSFC) [No: 82103954; 30972527; 81573233].
© 2022 The Author(s).

Entities:  

Keywords:  Associating factors; CI, Confidence interval; Meta-analysis; NOS, Newcastle-Ottawa Scale; RR, Risk ratio; Repetition; SA, Suicide attempt; SC, Self-cutting; SH, Self-harm; SP, Self-poisoning; Self-harm; Suicide

Year:  2022        PMID: 35747199      PMCID: PMC9126760          DOI: 10.1016/j.eclinm.2022.101461

Source DB:  PubMed          Journal:  EClinicalMedicine        ISSN: 2589-5370


Evidence before this study

A comprehensive search of PubMed, Web of Science, EMBASE, and PsycINFO was conducted to include longitudinal studies from January 2010 to April 2022 using search terms related to self-harm, repeated self-harm, suicide and cohort study. Although few reviews summarized the associating factors of suicide and repetition following self-harm, meta-analyses for pooling the comprehensive associating sociodemographic and clinic factors of suicide and repetition following self-harm, especially for specific types of psychiatric disorders, are lacking. Additionally, longitudinal evidence for associating factors of suicide and repetition following self-harm varied greatly.

Added value of this study

This meta-analysis and systematic review include a quantitative synthesis for a range of associating factors of suicide and repetition following self-harm from longitudinal studies with large samples. It updates the evidence from early reviews with studies published in recent 10 years and adds to the literature by synchronizing the findings on the influence of specific diagnoses of psychiatric disorders in the risk of suicide and repetition following self-harm. Specific diagnoses of psychiatric disorders including mood disorder and psychotic disorder were associated with increased risk of suicide and repetition following self-harm. Besides, substance use disorder, anxiety disorder, personality disorder, and eating disorder were associated with increased risk of self-harm repetition.

Implications of all available evidence

Strategies to address the associating factors could have some effects on intervention and prevention of subsequent self-harm and suicide. Implementing interventions such as regular follow-up of self-harm and valid treatment of psychiatric disorder should be considered. These insightful details found in this study could add some evidence for clinical care and self-harm prevention in the future. Alt-text: Unlabelled box

Introduction

Self-harm (SH) is an intentional act of self-poisoning and/or self-injury irrespective of motivation that induces huge burdens to economic costs, and disability-adjusted life years (DALYs) worldwide. Under this definition, suicide attempt, self-injury, parasuicide, and deliberate self-harm are also used to describe SH nomenclature., A history of SH not only implies an increased risk of recurrence,, but also increases the risk for mortality by all causes,, especially suicide. A recent meta-analysis summarizes that the prevalence of suicide and repetition following SH in one year is 1.3% and 17.0%, respectively. While SH repetition is more prevalent in female and young people, subsequent suicide is more prevalent in males and the elderly. A better understanding of factors deviating the risk for suicide and repetition following SH in the patients is vital for efforts to prevent such adverse outcomes. Two published reviews, to our knowledge have reported the associating factors for SH repetition. A review from Larkin et al. included 129 studies up to June 2012 found that previous SH, personality disorder, hopelessness, history of psychiatric treatment, schizophrenia, alcohol and substance misuses, and living alone were associated with repetition of SH. Another systematic review synthesized 27 studies focusing on adolescents and found psychiatric morbidity, features of previous SH, psychological distress, alcohol misuse, poor family, peer relationships, age, gender, and ethnicity being related to SH repetition. However, neither of the two reviews conducted a meta-analysis to quantify the strength of these associations. About associating factors for suicide following SH, a systematic review and meta-analysis included 12 prospective studies up to February 2014 and found previous episodes of SH, suicidal intent, physical health problems and male gender were highly related to eventually suicide. This study also pooled the risk scales of Beck Hopelessness Scale (BHS), the Suicide Intent Scale (SIS) and the Scale for Suicide Ideation (SSI) for suicide following SH. Although this review also pooled the estimates of psychiatric history, specific diagnosis of psychiatric disorder such as psychotic disorder, mood disorder and treatment of psychiatric disorder were not included for consideration; and the limited number of included studies affect the extrapolation of the conclusions. There was also a review on associating factors for suicide and repetition following suicide attempt, that searched for the studies between January 1991 to December 2009 and included 76 studies. This review identified important predictors of SH repetition that included previous attempt, being a victim of sexual abuse, poor global functioning, having a psychiatric disorder, being on psychiatric treatment, depression, anxiety, and alcohol abuse or dependence and the strongest predictors of suicide following SH were older age, suicide ideation, and history of suicide attempt. However, this review included case-control and cross-sectional studies and lacked longitudinal evidence and pooled results of associating factors. Despite of these reviews summarizing the associating factors with data from different time periods, meta-analysis on longitudinal evidence is needed to document associating sociodemographic and clinic factors on risk for suicide and repetition following SH in the general population. There is also a need to explore whether the estimates on the longitudinal association between associating factors and subsequent suicide and repetition following SH have varied by the used model, time of follow-up, sample size, definition of SH, and risk of bias. Considering the effect of time of follow-up on the associating factors and the review performed by Beghi et al. to include studies between January 1991 and December 2009, this systematic review and meta-analysis included the longitudinal studies published in recent 10 years (from January 2010 to April 2022), with the aims: i) to identify the sociodemographic and clinic factors of suicide and repetition following SH; ii) to explore the effect of the specific diagnosis and treatment of psychiatric disorders on suicide and repetition following SH; iii) to examine the effect of the used model, time of follow-up, sample size, definition of SH, and risk of bias on the pooled estimates; iv) compare the pooled results with previous reviews.

Methods

Search strategy

This systematic review was conducted in accordance with the PRISMA guidelines (http://www.prisma-statement.org/) and registered with PROSPERO (CRD42021248695). The databases used to search original studies included PubMed, Web of Science, EMBASE, and PsycINFO. Detailed search strategy could be found in the Supplementary material 1. Briefly, primary search terms included: (“attempted suicide” OR “deliberate self-harm” OR “self-harm” OR “self-injury” OR “self-poisoning”) and (“repeated self-harm” OR “suicide”) and (“cohort study” OR “population-based study” OR “follow-up”). Two investigators (YKY and XL) independently identified relevant studies published from January 1st, 2010, to April 5th, 2022, and compared with others until sorting out consistent records. The references of included studies and systematic reviews were also checked to identify additional studies that were not captured by our searching strategies.

Inclusion and exclusion criteria

Studies included in this meta-analysis met the following criteria: (1) had longitudinal data with a design of prospective or retrospective cohort study enabling calculation of the effect of associating factors on subsequent repetition and suicide following SH; (2) original research studies published in English (excluding case report, editorial comments, conference studies, randomized controlled trials, reviews, unpublished studies or doctoral theses); (3) had a clear definition of SH for the study participants and had SH repetition or suicide following SH as primary outcomes, which were recorded by the specific system or cohort for self-harm/death; (4) reported associating factors of suicide and repetition following SH with effect size (odds ratio, risk ratio, hazards ratio) and 95% confidence interval or raw data with cross tables. Studies were excluded if they aimed to study specific population such as single gender, veterans, or limited age groups, namely the studies focusing on the adolescents, the elderly and the middle-age population. Besides, included studies with sample size less than 100 were excluded in consideration of low incidence of outcomes and unstable results in these studies. For studies using the same database, only the one with the largest sample size was included. The studies reporting associating factors of suicide and repetition following SH using the data of presentation or episode of SH, which might have internal correlation for the same case, were excluded in consideration of intraclass correlation. The studies with cross-sectional design were excluded to get longitudinal estimates.

Data extraction

Extracted information included the name of first author, country or area, publication year, follow-up time, definition of SH (including self-harm, suicide attempt, self-poisoning or self-cutting under the definition of SH by Hawton), primary outcomes (suicide or repetition following SH, respectively), age range for included population, sample size, models (crude or adjusted model) used to report the associating factors and odds ratio/risk ratio/hazards ratio with 95%CI for included factors. Two researchers (BPL and YYZ) extracted information separately and discussed the discrepancies. Consistent follow-up time was recorded for the cohort with no censored data. Range, mean or median time of follow-up was recorded for cohort with censored and survival data. In order to explore the associations between pooled associating factors and follow-up time, mean or median time of follow-up was used to represent the concentration. For the studies only providing period of time, the result from sum of maximum and minimum time divided by two was used to represent the concentration of follow-up time. Long-term follow-up time was above 1 year for SH repetition and above 3.5 year for suicide following SH after calculating the median of follow-up time for all included studies. The sample size after taking the natural logarithm was used to analyze the associations with pooled associating factors owing to big differences for included studies. Learning from previous reviews and reports from included studies (only associating factors recorded in above two studies were included), sociodemographic factors such as age group, gender, employment, marital status, and educational level, and clinical factors such as multiple episodes of SH, physical illness, diagnosis, and treatment of psychiatric disorder were extracted for this review as the primary associating factor. Specific diagnoses of psychiatric disorder were extracted under the criteria of Structured Clinical Interview for the DSM-IV Disorders (SCID, 2002 Edition). Specific treatment of psychiatric disorder including psychiatric clinic and hospitalization were also extracted from included studies. Due to varying cut-offs of age groups (cut-off age of adolescents and younger adults and middle-aged adults: from 20 years to 34 years and cut-off age of middle-aged adults and the elderly: from 50 years to 65 years) among included studies, a somewhat flexible cutting point of age with clinical significances for dividing the lifespan into the adolescents and young adults, middle-aged adults, and the elderly was adopted when pooling the estimates related to age groups.

Quality assessment of the included studies

Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies. NOS included 8 items assessing the selection (4 items, 4 points), comparability (1 item, 2 points), and outcomes (3 items, 3 points) of every included study with the total scores of 9 points. A total score of 9 points for included studies were deemed to have a low risk of bias. The studies with two or three points for selection, one for comparability, and two for outcomes were considered to have medium risk of bias. The studies scored of zero or one point for selection or outcomes, and zero point for comparability were deemed to have a high risk of bias. Besides, a total score lower than 6 points for included studies were also deemed to have a high risk of bias in this meta-analysis.

Statistical analysis

The pooled associating factors for suicide and repetition following SH were performed using R version 3.6.4. OR/HR used in cohort studies was considered as RR in this meta-analysis. Adjusted RRs and their 95%CIs reported in these included studies were prioritized. Crude RRs and 95%CIs were also used if adjusted estimates were not available. Considering some studies only reported indexes from different subgroups such as age group, gender, specific psychiatric disorder and so on, the overall effect for each study was calculated based on heterogeneity between subgroups. Heterogeneity was tested with I2 statistics in this study. Random effect model (REM) with Dersimonian and Laird method was used to calculate the estimates. Subgroup analyses were performed to explore the risk of suicide and SH repetition for definition of SH, namely self-harm, self-poisoning, self-cutting and suicide attempt, and follow-up time for associating factors. Subgroup analyses of the specific diagnosis and treatment of psychiatric disorder were not performed because of limit number of include studies. Meta-regression was also performed to examine the potential sources of heterogeneity between studies according to sample and study characteristics such as risk of bias, sample size, adopted model, follow-up time, and definition of SH. To examine the stability of the pooled results, sensitivity analysis by leave-one-out methods (i.e., exclusion of one study at a time) was performed. Sensitivity analysis was also performed by omitting low-quality studies and to observe the effect by study quality . Begg's test and Egger's test were used to examine publication bias. Funnel plot was also used to detect publication bias. If existing publication bias, trim-and-fill method was used to detect the stability of pooled results. All the analyses were two-sided and P<0.05 was considered to be statistically significant.

Role of the funding source

The funders had no role in the study design, data collection, data analysis, data interpretation, or in the writing of the manuscript. All authors contributed to critical revision of the manuscript, had full access to all the data in the study and accept responsibility for the decision to submit for publication.

Results

Literature search and characteristics of included studies

Following search strategies shown in the Supplementary material 1, 9211 studies were identified, and 62 longitudinal studies were eventually included in this systematic review and meta-analysis. The flow diagram for including studies could be seen in the Figure 1. Of the included studies, 32 studies reported the associating factors of SH repetition,,25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55 21 studies reported the associating factors of suicide following SH,,56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75 and 9 studies both reported the associating factors of suicide and repetition following SH.,76, 77, 78, 79, 80, 81, 82, 83 For the definition of participants, 31 studies adopted SH, 26 studies adopted suicide attempt (SA), 4 adopted self-poisoning (SP) and 1 adopted self-cutting (SC). A total of 34 studies were based on data from Europe (UK 9, Sweden 8, and the others from Denmark, Norway, France, Italy, Spain, Ireland), 19 from Asia (Taiwan, China 13, and the others from Japan, Sri Lanka, mainland China and Japan), and 9 from America (USA 6 and Canada 3). The sample size of included studies was from 160 to 136,451. The item-based quality assessment by NOS for each included studies could be seen in the Supplementary material 2 and the risk of bias could be seen in the Table 1. Most of included studies scored 7 points or above (30/41) for SH repetition and (27/30) for suicide following SH associated with NOS. The number of included studies with low, medium, and high risk of bias were 2, 33, and 6 for SH repetition and 17, 10, and 3 for suicide following SH, respectively. The proportion of the males was from 22.9% to 54.0% in the studies of SH repetition and 25.0% to 49.7% in the studies of suicide following SH. More details of characteristics about included studies could be seen in the Table 1.
Figure 1

The PRISMA flow diagram showing process of study selection for inclusion in our meta-analyses.

Table 1

Characteristics of the included studies and assessment of risk of bias.

First author (year of publishment)Country or regionFollow-up time (Mean or Median or range)OutcomesAge rangeMale (%)Sample sizeIncluded factorsAssessment of risk of bias using NOS
Definition of SH: SH
Bergen (2010)UK0–2 yearsSHMedian: 30 years (IQR: 19 years)41.813,966Sociodemographic factors: gender.Clinical factors: history of SH, and treatment of psychiatric disorder.Medium risk
Bergen (2012)UK3–11 yearsSuicideMedian: 27 years (IQR: 19 years)35.030,202Sociodemographic factors: gender and employment.Clinical factors: history of SH and treatment of psychiatric disorder.Low risk
Bhaskaran (2014)Canada0.5 years (At least 0.5 years for all cases)SH18 years or above45.1922Sociodemographic factors: gender.Clinical factors: substance use disorder.Medium risk
Bilen (2011)Sweden0–3 yearsSH18 years or above35.01524Sociodemographic factors: gender, age, marital status, employment, and educational level.Clinical factors: history of SH, treatment of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, anxiety disorder, personality disorder, and psychiatric clinicMedium risk
Bilen (2014)Sweden0.5 years (At least 0.5 years for all cases)SH18 years or above28.3325Sociodemographic factors: gender and age.Clinical factors: history of SH, diagnosis of psychiatric disorder, and psychiatric clinic.Medium risk
Birtwistle (2017)UKMean: 4.4 yearsSuicide12 years or above42.06024Sociodemographic factors: gender and ageClinical factors: history of SH.Medium risk
Chen (2013)Taiwan, ChinaMean:1.43 yearsSuicide10–98 years29.43299Sociodemographic factors: gender, age, and employment.Clinical factors: physical illness and`diagnosis of psychiatric disorderLow risk
Chen (2011)Taiwan, ChinaMean: 5.8 yearsSuicide11–90 years36.31080Sociodemographic factors: gender, age, educational level, and marital statusLow risk
Chen (2010)Taiwan, ChinaMean: 3.7 yearsSH11–90 years37.0970Sociodemographic factors: gender, age, educational level, and marital statusMedium risk
Chung (2012)Taiwan, China0–8 yearsSHAll age groups but not identifying the range46.139,875Sociodemographic factors: gender and age.Clinical factors: physical illness and diagnosis of psychiatric disorder.Low risk
Chung (2013)Taiwan, China0–8 yearsSuicide10 years or above43.53388Sociodemographic factors: gender and age.Clinical factors: physical illness and diagnosis of psychiatric disorder.Medium risk
Corcoran (2015)UK1 year (At least 1 year for all cases)SHAll age groups but not identifying the range46.33337Sociodemographic factors: gender and age.Clinical factors: history of SH.Medium risk
Cully (2021)Ireland0–1 yearSH18 years or above52.8324Sociodemographic factors: gender.Clinical factors: treatment of psychiatric disorderMedium risk
Hawton (2015)UK2–13 yearsSuicide7–97 years41.540,346Sociodemographic factors: gender and age.High risk
Kapur (2015)UK0–1 yearsSuicide10 years or above43.038,415Clinical factors: psychiatric hospitalizationLow risk
Kawahara (2017)Japan0–0.5 yearsSH12–88 years29.9405Sociodemographic factors: gender, marital status, and employment.Clinical factors: history of SH, treatment of psychiatric disorder, physical illness, and psychiatric hospitalizationMedium risk
Knipe (2019)Sri LankaMedian:1.9 yearsSH10 years or above49.72259Sociodemographic factors: gender and age.Clinical factors: history of SH.Medium risk
SuicideMedium risk
Kuo (2012)Taiwan, ChinaMedian: 3.3 yearsSuicide15 years or above27.88343Sociodemographic factors: gender and age.Low risk
Kwok (2014)Taiwan, ChinaMedian: 1.4 yearsSH15–96 years30.57601Sociodemographic factors: gender, age, and marital status.Clinical factors: history of SH.Medium risk
Lindh (2018)Sweden0.5 year (At least 1 year for all cases)SH18–95 years33.0804Sociodemographic factors: gender.High risk
SuicideHigh risk
Madsen (2013)DenmarkMean: 4.2 yearsSuicide18 years or above45.217,257Sociodemographic factors: employment, educational level, and marital status.Clinical factors: Mood disorder, psychotic disorder, substance use disorder, personality disorder, and psychiatric clinic.Medium risk
Miller (2013)US0–5 yearsSH15 years or above41.63600Sociodemographic factors: gender and age.Clinical factors: diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, anxiety disorder, and personality disorder.Low risk
SuicideLow risk
Olfson (2013)US0.08 yearsSH21–64 years31.85567Sociodemographic factors: gender and age.Clinical factors: diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, anxiety disorder, adjustment disorder and personality disorder.Medium risk
Olfson (2017)US0–1 yearsSH18–64 years33.061,054Sociodemographic factors: gender and age.Clinical factors: treatment of psychiatric disorder, psychiatric hospitalization, and psychiatric clinic.Medium risk
Suicide
Perry (2012)Ireland0–1 yearsSH10 years or aboveNot available48,206Sociodemographic factors: age.Clinical factors: history of SHMedium risk
Riedi (2012)France0.5 years (At least 0.5 years for all cases)SHMean: 37.8 years (SD: 12.1 years)29.0184Sociodemographic factors: gender and employment.Clinical factors: diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, and anxiety disorderHigh risk
Runeson (2016)SwedenMean: 5.3 yearsSuicide10 years or above40.634,219Sociodemographic factors: gender.Clinical factors: diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, anxiety disorder, and personality disorder.Low risk
Steeg (2018)UK1 year (At least 1 years for all cases)Suicide16 years or above42.031,715Clinical factors: psychiatric hospitalization, and psychiatric clinic.Low risk
Thomas (2021)US2 yearsSH5 years or above37.09518Sociodemographic factors: age and gender.Clinical factors: diagnosis of psychiatric disorderMedian risk
SuicideSociodemographic factors: age and gender.Clinical factors: diagnosis of psychiatric disorder and history of SHLow risk
Tidemalm (2015)Sweden9–19 yearsSuicide10 years or above42.453,843Sociodemographic factors: gender and age.Clinical factors: diagnosis of psychiatric disorder and history of SH.Low risk
Vuagnat (2019)France0–1 yearsSuicide16 years or above37.2136,451Sociodemographic factors: gender.Clinical factors: history of SH.Medium risk
Definition of SH: SA
Aguglia (2020)Italy0–0.5 yearsSA18 years or above22.9432Sociodemographic factors: gender, marital status, and employment.Clinical factors: history of SA, mood disorder, and psychotic disorderMedium risk
Chen (2016)Taiwan, China0–3 yearsSAAll age groups but not identifying the range33.051,579Sociodemographic factors: gender and ageMedium risk
Suicide25.06485Medium risk
Chen (2013)Taiwan, China0–0.5 yearsSAMean: 38 years (SD: 15 years)31.61056Sociodemographic factors: gender and employment.Clinical factors: diagnosis of psychiatric disorder and history of SA.Medium risk
Chung (2021)Taiwan, China0–16 yearsSA10 years or above45.624,300Sociodemographic factors: gender and age.Clinical factors: physical illness and diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, and psychiatric hospitalization.Medium risk
Demesmaeker (2021)France0–1.17 yearsSA18 years or above36.4972Sociodemographic factors: gender, age, marital status, and employment.Clinical factors: history of SA, diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, anxiety disorder, and eating disorder.Medium risk
Espandian (2020)Spain1 year (At least 1 year for all cases)SA18 years or above25.7319Sociodemographic factors: gender, marital status, employment, and educational level.Clinical factors: history of SA, mood disorder, psychotic disorder, personality disorder, anxiety disorder and adjustment disorder.Medium risk
Exbrayat (2017)France1 year (At least 1 year for all cases)SA18 years or above30.4823Sociodemographic factors: gender and employment.Clinical factors: history of SA, mood disorder, psychotic disorder, personality disorder, anxiety disorder, eating disorder, and psychiatric hospitalization.Medium risk
Fedyszyn (2016)Denmark0–16 yearsSAAll age groups but not identifying the rangeNot available11,802Sociodemographic factors: gender.Clinical factors: treatment of psychiatric disorder.Medium risk
SuicideClinical factors: psychiatric hospitalizationLow risk
Fossi (2021)France0.5 yearsSAMean: 40.6 (SD: 15.0 years)41.310,666Sociodemographic factors: gender.Clinical factors: history of SAMedium risk
Haglund (2016)Sweden0.5 year (At least 0.5 year for all cases)SA10–92 years37.5355Sociodemographic factors: gender.High risk
SuicideHigh risk
Huang (2014)Taiwan, China1–6 yearsSAMean: 40.5 years (SD:15.6 years)32.72070Sociodemographic factors: gender, age, marital status, and educational level.Medium risk
Irigoyen (2019)SpainMean: 1.7 yearsSA18 years or above33.4371Sociodemographic factors: gender and age.Clinical factors: history of SA, diagnosis of psychiatric disorder, mood disorder, psychotic disorder, substance use disorder, anxiety disorder, adjustment disorder, and personality disorder.Medium risk
Johannessen (2011)Norway0–5 yearsSA15 years or above31.71304Sociodemographic factors: gender, marital status, and employment.Clinical factors: history of SA.Medium risk
0–20 yearsSuicideMedium risk
Lipsicas (2014)Multiple countries from Europe1 years (At least 1 years for all cases)SAMean: 36.3 years (SD: 16.7 years)40.511,942Sociodemographic factors: gender.Medium risk
Liu (2022)China0–10 yearsSuicide15–70 years36.31103Sociodemographic factors: gender and marital status.Clinical factors: physical illness and history of SA, diagnosis of psychiatric disorder.Low risk
Mehlum (2010)Norway0–5.5 yearsSA18 years or above34.8911Sociodemographic factors: gender, age, marital status, and employment.Clinical factors: physical illness and treatment of psychiatric disorder.Medium risk
Monnin (2012)France0–2 yearsSA20 years or above30.8273Clinical factors: treatment of psychiatric disorder, history of SA, anxiety disorder, psychotic disorder, and substance use disorder.Medium risk
O'Connor (2012)UK2 years (At least 2 years for all cases)SA16 years or above36.7237Sociodemographic factors: gender, marital status, and employment.Clinical factors: history of SA.Medium risk
O'Connor (2017)US0.5 years (At least 0.5 years for all cases)SAMean: 37.3 years (SD: 10.54 years)54.0160Sociodemographic factors: gender.Clinical factors: history of SA.High risk
Pan (2013)Taiwan, ChinaMedian: 1.4 yearsSuicide15 years or above33.550,805Sociodemographic factors: gender.Clinical factors: diagnosis of psychiatric disorder.Medium risk
Parra-Uribe (2017)Spain1 years (At least 1 years for all cases)SAMean: 40.8 years (SD: 16.0 years)37.61241Sociodemographic factors: gender, age, marital status, educational level, and employment.Clinical factors: personality disorder.Medium risk
Pavarin (2014)Italy0–8.5 yearsSuicideMean: 45.6 years39.4505Sociodemographic factors: gender and age.Low risk
Runeson (2010)Sweden21–31 yearsSuicide10 years or above48.448,649Sociodemographic factors: gender.Clinical factors: diagnosis of psychiatric disorder, psychotic disorder, and mood disorder.Low risk
Sawa (2017)JapanMean: 3.7 yearsSAMean: 39.8 years31.6291Sociodemographic factors: gender.Clinical factors: diagnosis of psychiatric disorder, mood disorder, substance use disorder, psychotic disorder, and personality disorder.Medium risk
Wang (2015)Taiwan, China1–6 yearsSuicideMean:40.4 years (SD: 15.6 years)32.42052Sociodemographic factors: gender, age, educational level, and marital status.Medium risk

Definition of SH: SC
Carroll (2016)UKMean: 2.1 yearsSuicide14- 101 years41.13928Sociodemographic factors: gender.Clinical factors: history of SC, diagnosis of psychiatric disorder, mood disorder, and personality disorderLow risk

Definition of SH: SP

Finkelstein (2015)CanadaMedian: 5.3 yearsSuicideMedian: 32 years (IQR:25 years)38.365,784Sociodemographic factors: gender and age.Clinical factors: history of SP, mood disorder, and substance use disorder.Low risk
Finkelstein (2016)CanadaMedian:4.3 yearsSP10 years or above38.281,675Sociodemographic factors: gender and age.Clinical factors: mood disorder, and substance use disorder.Medium risk
Pushpakumara (2019)Sri Lanka0.08 years (At least 0.08 years for all cases)SP10 years or above50.84022Sociodemographic factors: gender.High risk
Rajapakse (2016)Sri Lanka1 years (At least 1 years for all cases)SP14 years or above44.2335Sociodemographic factors: gender.High risk

SH: self-harm, SD: standard deviation, IQR: interquartile range, NOS: Newcastle-Ottawa Scale, SA: suicide attempt, SP: self-poisoning, SC: self-cutting.

The PRISMA flow diagram showing process of study selection for inclusion in our meta-analyses. Characteristics of the included studies and assessment of risk of bias. SH: self-harm, SD: standard deviation, IQR: interquartile range, NOS: Newcastle-Ottawa Scale, SA: suicide attempt, SP: self-poisoning, SC: self-cutting.

Associating factors for SH repetition

Figure 2 shows the associating factors related to SH repetition. The forest plots of associating factors for SH repetition could be seen in the Supplementary material 3. The number of included participants for pooling the associating factors was between 1795 and 365856 and the number of included studies for pooling associating factors was between 2 and 39.
Figure 2

Characteristics, heterogeneity, and pooled estimates for sociodemographic and clinical factors associated with risk for SH repetition (No.: number, RR: risk ratio, CI: confidence interval. Horizontal line span 1 represented statistically significant. The reference for middle-aged adults and elderly was adolescent and young adults. Each line represented a pool estimate by meta-analysis.).

Characteristics, heterogeneity, and pooled estimates for sociodemographic and clinical factors associated with risk for SH repetition (No.: number, RR: risk ratio, CI: confidence interval. Horizontal line span 1 represented statistically significant. The reference for middle-aged adults and elderly was adolescent and young adults. Each line represented a pool estimate by meta-analysis.). The sociodemographic factors including female gender (RR: 1.11, 95%CI: 1.04–1.18, I2=82.8%), and a marital status of being single (RR: 1.13, 95%CI: 1.03–1.25, I2=25.5%) were found to be associated with increased risk of SH repetition. Compared with adolescents and young adults, the elderly had a lower risk of SH repetition (RR: 0.67, 95%CI: 0.52–0.87, I2=86.3%). Employment and educational level were not found to have statistically significant associations with SH repetition. Clinical factors showed stronger associations with SH repetition compared with sociodemographic factors. Multiple episodes of SH (RR: 1.97, 95%CI: 1.51–2.57, I2=94.3%), diagnosis of psychiatric disorder (RR: 1.60, 95%CI: 1.27–2.02, I2=92.7%), and treatment of psychiatric disorder (RR: 1.59, 95%CI: 1.40–1.80, I2=93.3%) were all found to be associated with increased risk of SH repetition. Some specific diagnoses of psychiatric disorders including mood disorder (RR: 1.23, 95%CI: 1.07–1.40, I2=69.8%), psychotic disorder (RR: 1.39, 95%CI: 1.11–1.74, I2=58.3%), substance use disorder (RR: 1.42, 95%CI: 1.21–1.66, I2=81.4%), anxiety disorder (RR: 1.53, 95%CI: 1.20–1.95, I2=66.8%), eating disorder (RR: 1.67, 95%CI: 1.19–2.34, I2=0) and personality disorder (RR: 1.79, 95%CI: 1.43–2.24, I2=63.0%) were associated with increased risk of SH repetition. However, there was not statistically significance between adjustment disorder and SH repetition. Specific methods of treatment of psychiatric disorders such as psychiatric clinic (RR: 1.31, 95%CI: 1.22–1.42, I2=9.8%) and psychiatric hospitalization (RR: 1.45, 95%CI: 1.13–1.86, I2=54.5%) were both related to have increased risk of SH repetition. Besides, physical illness was not found to have statistically significant associations with SH repetition. The forest plots of associating factors for SH repetition and more details about the pooled estimates could be seen in the supplementary material 3.

Associating factors for suicide following SH

Associating factors for suicide following SH could be seen in the Figure 3. The number of included participants for pooling the associating factors was between 7790 and 576,842 and the number of included studies for pooling associating factors was between 2 and 26.
Figure 3

Characteristics, heterogeneity, and pooled estimates for sociodemographic and clinical factors associated with risk for suicide following self-harm (No.: number, RR: risk ratio, CI: confidence interval, horizontal line span 1 represented statistically significant. The reference for middle-aged adults and elderly was adolescent and young adults. Each line represented a pool estimate by meta-analysis).

Characteristics, heterogeneity, and pooled estimates for sociodemographic and clinical factors associated with risk for suicide following self-harm (No.: number, RR: risk ratio, CI: confidence interval, horizontal line span 1 represented statistically significant. The reference for middle-aged adults and elderly was adolescent and young adults. Each line represented a pool estimate by meta-analysis). Among the sociodemographic factors, male gender (RR: 2.03, 95%CI: 1.80–2.28, I2=83.8%), middle-aged adults (RR: 2.40, 95%CI: 1.87–3.08, I2=74.4%), and the elderly (RR: 4.38, 95%CI: 2.98–6.44, I2=76.8%) were significantly associated with increased risk of suicide following SH. Compared with high school or above, under high school had a lower risk of suicide following SH (RR: 0.74, 95%CI: 0.62–0.87, I2=0). Unemployment and a marital status of being single were not found to have statistically significant associations with SH repetition. Some clinical factors showed significant effect on suicide following SH. Physical illness (RR: 1.95, 95%CI: 1.56–2.43, I2=0), multiple episodes of SH (RR: 2.02, 95%CI: 1.58–2.58, I2=87.4%), diagnosis of psychiatric disorder (RR: 2.13, 95%CI: 1.67–2.71, I2=90.9%), and treatment of psychiatric disorder (RR: 1.36, 95%CI: 1.16–1.58, I2=58.6%) were all found to be associated with increased risk of suicide following SH. Some specific diagnoses of psychiatric disorders including mood disorder (RR: 1.76, 95%CI: 1.27–2.44, I2=94.2%), and psychotic disorder (RR: 2.34, 95%CI: 1.10–4.97, I2=97.2%) were associated with increased risk of suicide following SH. However, there was not statistically significance between other types of psychiatric disorders and suicide following SH. Specific methods of treatment of psychiatric disorders such as psychiatric hospitalization (RR: 1.19, 95%CI: 0.84–1.69, I2=64.9%) were also not found to have statistically significant associations with suicide following SH. Psychiatric clinic (RR: 1.47, 95%CI: 1.24–1.74, I2=84.2%), which included only three records, was found to be associated with suicide following SH. The forest plots of associating factors for suicide following SH and more details about the pooled estimates could be seen in the supplementary material 3.

Subgroup analysis and heterogeneity

Subgroup analyses by follow-up time were additionally performed and shown in the Supplementary material 4. The associating factors including the elderly, female gender, a marital status of being single, multiple episodes of SH, and diagnosis and treatment of psychiatric disorder seemed to have a significant effect on SH repetition in the group of long-term follow-ups. Middle-aged adult, unemployment, multiple episodes of SH, and diagnosis and treatment of psychiatric disorder were significantly associated with increased risk of suicide following SH in the group of short-term follow-ups. Apart from significant association of treatment of psychiatric disorder with suicide following SH in the group of short-term period, the estimates of other associating factors were similar with total estimates regardless of follow-up time. The heterogeneity of associating factors decreased in the subgroup analysis of follow-up time, namely middle-aged adult, female gender, unemployment and physical illness in the short-term period and a marital status of being single in the long-term period for SH repetition and middle-aged adult, male gender, multiple episodes of SH, diagnosis and treatment of psychiatric disorder in the short-term period for suicide following SH. Subgroup analysis by the definition of SH was also performed in this study. The details could be seen in the Table 2. Consistent with total estimates, the elderly, multiple episodes of SH, and treatment of psychiatric disorder were significantly associated with SH repetition and advancing age (middle-aged adults and the elderly), male gender, diagnosis of psychiatric disorder was associated with increased risk of suicide following SH. Differently, the associating factors including female gender and diagnosis of psychiatric disorder seemed only to have a significant effect on SH repetition among suicide attempters and a marital status of single was only related to SH repetition among the cases with a definition of SH/SP/SC. Physical illness, treatment of psychiatric disorder and multiple episodes of SH were only significantly associated with increased risk of suicide following SH among the cases with a definition of SH/SP/SC. The heterogeneity of associating factors decreased in the subgroup analysis of the definition of SH, namely physical illness under the definition of SH/SP/SC for SH repetition and middle-aged adult under the definition of SA and male gender and treatment of psychiatric disorder under the definition of SH/SP/SC for suicide following SH.
Table 2

Subgroup analyses by the definition of self-harm.

Associating factorsSH repetition
Suicide following SH
Definition of SH: SH/SP/SC
Definition of SH: SA
Definition of SH: SH/SP/SC
Definition of SH: SA
nRR (95%CI), I2nRR (95%CI), I2nRR (95%CI), I2nRR (95%CI), I2
Sociodemographic factors
Middle-aged (Ref. adolescent and young adults)131.02 (0.94–1.10), 79.3%71.08 (0.85–1.36), 80.2%122.48 (1.84–3.35), 80.2%42.21 (1.55–3.16), 0
Elderly (Ref. adolescent and young adults)110.74 (0.58–0.96), 72.7%70.56 (0.38–0.82), 83.0%114.05 (2.59–6.33), 80.8%45.69 (2.45–13.18), 57.3%
Gender*191.07 (0.99–1.15), 75.3%201.15 (1.03–1.29), 83.1%172.08 (1.95–2.22), 26.6%91.72 (1.39–2.12), 69.3%
Single/divorced/separated/widowed41.19 (1.03–1.37), 30.0%81.09 (0.95–1.24), 27.5%20.97 (0.68–1.39), 47.4%31.03 (0.69–1.53). 0
Unemployment31.06 (0.60–1.86), 63.3%91.09 (0.92–1.29), 44.1%31.08 (0.69–1.70), 68.3%12.11 (1.11–3.99), NA
Under high school21.08 (0.93–1.26), 030.96 (0.78–1.18), 020.73 (0.62–0.87), 010.79 (0.39–1.60), NA
Clinical factors
Physical illness21.11 (0.98–1.25), 021.93 (0.64–5.87), 94.4%22.15 (1.36–3.40), 34.8%11.41 (0.50–3.99), NA
Multiple episodes of SH82.24 (1.58–3.19), 93.5%111.77 (1.14–2.74), 94.1%82.05 (1.57–2.66), 89.8%22.02 (0.74–5.50), 65.4%
Diagnosis of psychiatric disorder61.32 (0.99–1.75), 91.6%52.29 (1.38–3.81), 94.4%72.44 (1.83–3.25), 65.9%41.81 (1.33–2.45), 76.8%
Treatment of psychiatric disorder61.47 (1.30–1.66), 91.8%51.90 (1.30–2.78), 84.1%51.35 (1.19–1.53), 37.3%20.80 (0.16–4.12), 90.1%

Male gender and female gender as the reference groups for suicide and repetition following self-harm, respectively.

SA: suicide attempt, SH: self-harm, SP: self-poisoning, SC: self-cutting, RR: risk ratio, CI: confidential interval.

n: The number of studies included in the subgroup analysis.

NA: I2 is not available when there was only one study included in the estimates.

Subgroup analyses by the definition of self-harm. Male gender and female gender as the reference groups for suicide and repetition following self-harm, respectively. SA: suicide attempt, SH: self-harm, SP: self-poisoning, SC: self-cutting, RR: risk ratio, CI: confidential interval. n: The number of studies included in the subgroup analysis. NA: I2 is not available when there was only one study included in the estimates.

Meta-regression and heterogeneity

The heterogeneity (I2) of included associating factors varied in this study (Figs. 2 and 3). Respective meta-regression model for each associating model was presented in the Table 3. As for SH repetition, adjusted model could result in higher estimates for diagnosis of adjustment disorder and lower estimates for diagnosis of substance use disorder. The RRs associated with unemployment diagnosis of anxiety disorder and psychiatric hospitalization were significantly smaller and female gender was significantly larger in size as the follow-up time increased. Higher estimates of multiple episodes of SH and diagnosis of adjustment disorder and lower estimates of the elderly (compared with adolescent and young adults), diagnosis of substance use disorder, and treatment of psychiatric disorder were independently associated with larger sample size. Suicide attempt as the definition of SH could result in higher estimates for diagnosis of personality disorder and lower estimates for diagnosis of adjustment disorder.
Table 3

Factors associated with heterogeneity assessed by meta-regression analysis.

Associating factorsSH repetition, slope (P)
Suicide following self-harm, slope (P)
Adjusted model (Ref: crude model)Long-term follow-up (Ref: short-term follow-up)Sample size (ln)SA as the definition of SH (Ref: SH/SP/SC)Adjusted model (Ref: crude model)Long-term follow-up (Ref: short-term follow-up)Sample size (ln)SA as the definition of SH (Ref: SH/SP/SC)
Sociodemographic factors
Middle-aged (Ref. adolescent and young adults)0.034 (0.640)−0.106 (0.113)−0.074 (0.146)0.047 (0.585)−0.436 (0.103)0.004 (0.990)0.317 (0.105)−0.159 (0.622)
Elderly (Ref. adolescent and young adults)−0.165 (0.565)−0.380 (0.139)−0.424 (0.002)−0.302 (0.192)−1.048 (0.011)−0.507 (0.229)0.232 (0.462)0.342 (0.472)
Gender*0.111 (0.084)0.154 (0.009)0.066 (0.135)0.092 (0.148)−0.012 (0.924)−0.009 (0.941)−0.050 (0.595)−0.247 (0.004)
Single/divorced/separated/widowed0.150 (0.122)0.141 (0.195)0.044 (0.723)−0.094 (0.361)−0.247 (0.179)−0.292 (0.326)−0.223 (0.181)0.135 (0.535)
Unemployment−0.181 (0.337)−0.295 (0.048)−0.482 (0.062)0.127 (0.560)−0.669 (0.192)−0.863 (0.177)−0.749 (0.023)0.669 (0.192)
Under high school−0.135 (0.337)0.007 (0.973)−0.213 (0.621)−0.118 (0.365)0.041 (0.875)−0.076 (0.838)−0.033 (0.890)0.076 (0.838)
Clinical factors
Physical illness0.207 (0.763)0.474 (0.496)0.220 (0.588)0.493 (0.420)⁎⁎⁎−0.579 (0.203)0.848 (0.516)−0.422 (0.500)
Multiple episodes of SH0.304 (0.296)−0.061 (0.842)0.500 (0.014)−0.235 (0.411)0.198 (0.473)−0.159 (0.582)0.041 (0.831)−0.088 (0.817)
Diagnosis of psychiatric disorder0.076 (0.757)0.161 (0.543)−0.142 (0.389)0.505 (0.059)0.408 (0.096)0.075 (0.778)0.245 (0.250)−0.308 (0.151)
Mood disorder0.016 (0.906)−0.028 (0.853)0.010 (0.894)0.029 (0.845)0.522 (0.242)0.249 (0.550)0.132 (0.739)−0.059 (0.924)
Psychotic disorder−0.345 (0.088)−0.221 (0.381)−0.205 (0.216)−0.014 (0.955)1.001 (0.314)−0.068 (0.944)0.456 (0.635)0.320 (0.810)
Substance use disorder−0.400 (0.040)−0.140 (0.428)−0.261 (0.037)0.035 (0.840)0.343 (0.499)−0.163 (0.778)−0.045 (0.940)⁎⁎⁎
Anxiety disorder−0.379 (0.193)−0.529 (0.001)−0.352 (0.169)0.440 (0.057)⁎⁎⁎⁎⁎⁎⁎⁎
Personality disorder0.251 (0.350)0.069 (0.806)−0.174 (0.536)0.468 (<0.001)1.250 (<0.001)−0.090 (0.926)0.266 (0.804)⁎⁎⁎
Adjustment disorder0.760 (0.039)−0.284 (0.716)0.628 (0.038)−0.760 (0.039)⁎⁎⁎⁎⁎⁎⁎⁎
Treatment of psychiatric disorder0.035 (0.838)−0.033 (0.793)−0.157 (0.025)0.245 (0.055)0.036 (0.886)0.018 (0.917)0.346 (0.183)−0.089 (0.722)
Psychiatric clinic−0.286 (0.136)−0.080 (0.740)−0.067 (0.328)⁎⁎⁎0.219 (0.194)−0.219 (0.194)0.327 (0.386)⁎⁎⁎
Psychiatric hospitalization⁎⁎⁎−0.407 (0.025)−0.228 (0.130)−0.302 (0.319)⁎⁎⁎−0.207 (0.652)0.656 (0.109)−0.207 (0.652)

Male gender and female gender as the reference groups for suicide and repetition following self-harm, respectively.

Meta-regression was only performed when the number of included articles was above 3 records.

Only one category was found in the corresponding variable.

SA: suicide attempt, SH: self-harm, SP: self-poisoning, SC: self-cutting.

Factors associated with heterogeneity assessed by meta-regression analysis. Male gender and female gender as the reference groups for suicide and repetition following self-harm, respectively. Meta-regression was only performed when the number of included articles was above 3 records. Only one category was found in the corresponding variable. SA: suicide attempt, SH: self-harm, SP: self-poisoning, SC: self-cutting. As for suicide following SH, adjusted model resulted in lower estimates for the elderly and higher estimates for diagnosis of personality disorder. Lower estimates of unemployment were independently associated with larger sample size. Suicide attempt as the definition of SH resulted in lower estimates for male gender. Due to the substantial heterogeneity found in this study, these results need to be interpreted with caution.

Sensitivity analysis and publication bias

Sensitivity analyses were performed for each associating factor related to suicide and repetition following SH by excluding one study at a time. The combined RR of overall risk estimates were relatively consistent and without apparent fluctuation. Although the pooled RRs did not materially change in term of strength of effects in the sensitivity analyses, some included studies might result in changes in statistical significance, such as adjustment disorder of SH repetition, and educational level, physical illness, psychotic disorder, personality disorder, and psychiatric hospitalization of suicide following SH. More details could be seen in the Supplementary material 5. The analyses did not substantially change the pooled estimates by deleting the studies with high risk of bias (Supplementary material 6). Funnel plots for each meta-analysis in this study are presented in Supplementary material 7. Although the funnel plots showed relatively minimal asymmetry for these meta-analyses, analyses for publication bias were only found for the estimates of gender of suicide following SH (P = 0.021) by Egger test. After adjusting for funnel plot asymmetry by trim-and-fill methods, male gender was still associated with increased risk of suicide following SH (RR: 1.75, 95%CI: 1.57–1.95, I2=83.8%). Begg test and Egger test for other meta-analyses could be seen in the Supplementary material 8.

Discussion

Previous reviews summarized that male gender, and elder age were associated with suicide following SH. Our results from meta-analyses are in line with these findings and further showed that the risk of suicide following SH for the males is two folds higher than that in females, and that the risk of suicide following SH in the middle-aged adults and the elderly is 2.4 and 4.4 times higher than that in the younger age. The finding of middle-aged adults increasing the risk of suicide attempt repetition in a previous appraisal is different from the estimates in this study. However, our study supported that the elderly has lower risk of SH repetition. Another finding is that the risk of SH repetition in the females was slightly higher than that in the males, which was not reported in the previous reviews. The characteristics of age and gender related to suicide and repetition following SH should be paid more attention and could provide some evidence for SH and suicide prevention. The study of Beghi et al. mentioned that the role of demographic factors on risk for suicide and repetition following SH is less clear. Our finding showed that only living in a single marital status was related to SH repetition and educational level was related to suicide following SH. The possible explanation is that SH repetition occurs more often in the short time after SH, while death by suicide tends to occur in the long period after SH. The socioeconomic factors at the time of initial SH may have changed greatly when repeated SH or suicide occurs. Compared with some clinical factors, the influence of demographic and socioeconomic factors may be weaker. Consistent with a previous systematic review,, this review also found physical illness was associated with increased risk of suicide following SH, but not for SH repetition. These findings could be explained by the high suicide intent in the population of SH with physical illness. Consistent with previous reviews,13, 14, 15 multiple episodes of SH, and diagnosis of psychiatric disorder were highly associated with increased risk of suicide and repetition following SH. This review moreover examined the risk of suicide and repetition following SH associated with specific diagnoses of psychiatric disorders, which could add some evidence for clinical prevention of adverse outcomes of SH. Personality disorder are at the highest risk of SH repetition and psychotic disorder at the highest risk of suicide following SH. In addition, psychiatric treatment, whether psychiatric clinic or hospitalization does not seem to have the effect on decreasing the risk of suicide and repetition following SH. Kapur et al. using a large cohort of UK found that most aspects of management were not significantly associated with increased risk of total mortality and suicide in adjusted models. The hospitals and clinical services might be assigning the most intensive management to the highest risk patients. In that case, psychiatric hospitalization, as the minority of cases for SH, is associated with higher risk of suicide and repetition following SH compared with mild SH. However, Kapur et al. also mentioned that psychiatric admission might be a life-saving intervention for some high-risk population. More randomized controlled trials are needed to explore the associations in the future. The review of Beghi et al. mentioned that associating factors of suicide and repetition following suicide attempt were not comparable for meta-analysis in consideration of different designs and follow-up time. Therefore, this review and meta-analysis included the longitudinal studies of recent 10 years to obtain stable and trustable estimates. Although heterogeneity for some of meta-analytic associating factors were relatively high, relative factors including adopted model, follow-up time, sample size, definition of SH, and risk of bias were used to explore the potential sources of heterogeneity by meta-regression models. Besides, stabilization of pooled estimates was also examined by sensitivity analyses of leave-one-out method. Unstable meta-analytic estimates are from diagnosis of psychiatric disorder,,,,, educational level, physical illness and psychiatric hospitalization. These studies included some studies with a shorter time of follow-up (30 days), which might have contributed to high heterogeneity for the specific diagnoses of psychiatric disorders. The reason of unstable estimates of educational level and psychotic disorder caused by study of Madsen might be included cases in this study only including SH before psychiatric admission. The study of Bostwick found that psychiatric hospitalization was associated with decreased risk of suicide following SH, which was conflict with the other included studies. Although this study taking advantage of long-term follow-up, the small cohort of the patients (1442 for prospective design) might underpower the results for the associations between psychiatric hospitalization and suicide. Chung et al. used the data of repeated self-harm to explore the association of physical illness with suicide and might exaggerate the effect of physical illness because of poor condition compared with the cases of first self-harm. Some other factors such as different methods of diagnosis and treatment of psychiatric disorders, cultural characteristics, provision of health services, and the loss of follow-up might have an effect on heterogeneity. However, some limitations need to be acknowledged. First, due to the contextual heterogeneity of pooling estimates of the included studies, these findings need to be taken with considerable caution. More studies are needed to explore the factors which could have effect on the estimates. Second, the cut-offs of age band were not fixed because of different criteria among the included studies. However, adolescents and young adults, middle-aged adults and the elderly were used to distinguish the different period in the life and might have more clinical implications. Third, the number of included studies is relatively small for some associating factors, extrapolation of this conclusion should be interpreted with caution. Fourth, included studies from low-and-middle-income countries are few, more studies are warranted in this area. Finally, only English-written studies were included, which might lead to selection bias towards findings from Western countries. In conclusion, a range of sociodemographic and clinical factors are identified to increase the longitudinal risk of suicide and repetition following SH. Female adolescents and male elder with self-harming behaviors should be paid more attention with the higher risk of suicide and repetition following SH, respectively. What's more, comorbidity of self-harm and psychiatric disorder and multiple repetition of SH are other concerns for preventing adverse outcomes of SH. Strategies to address these associating factors could have some effects on intervention and prevention of subsequent SH and suicide. Implementing interventions such as regular follow-up of SH and valid treatment of psychiatric disorder should be considered. The insightful details found in this study could inform personalized clinical care and suicide preventions in SH patients as a high-risk group.

Data sharing statement

The study protocol is registered in the International Prospective Register of Systematic Reviews (CRD42021248695). Raw data are available upon request from jiacunxian@sdu.edu.cn or shixueli@sdu.edu.cn.

Funding

This work was supported by (NSFC) [No: 82103954; 30972527; 81573233].

Contributors

BPL, PQ, SXL and CXJ formulated the research question and design the study. BPL, YYZ, YKY, and XL contributed the acquisition and extraction of data, and quality assessment. BPL analyzed the data and wrote the first draft of the manuscript. All authors contributed to critical revision of the manuscript, had full access to all the data in the study and accept responsibility for the decision to submit for publication.

Declaration of interests

The authors have declared that no competing interests exist.
  82 in total

1.  Is organizational change associated with increased rates of readmission to general hospital in suicide attempters? A 10-year prospective catchment area study.

Authors:  Lars Mehlum; Trond Jørgensen; Lien My Diep; Latha Nrugham
Journal:  Arch Suicide Res       Date:  2010

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Mortality and suicide after self-harm: community cohort study in Taiwan.

Authors:  Vincent C H Chen; Happy K L Tan; Chung-Ying Chen; Tony H H Chen; Long-Ren Liao; Charles T C Lee; Michael Dewey; Robert Stewart; Martin Prince; Andrew T A Cheng
Journal:  Br J Psychiatry       Date:  2011-01       Impact factor: 9.319

4.  Non-fatal repetition of self-harm: population-based prospective cohort study in Taiwan.

Authors:  Vincent C H Chen; Happy K L Tan; Andrew T A Cheng; Chung-Ying Chen; Long-Ren Liao; Robert Stewart; Michael Dewey; Martin Prince
Journal:  Br J Psychiatry       Date:  2010-01       Impact factor: 9.319

5.  Age-specific suicide mortality following non-fatal self-harm: national cohort study in Sweden.

Authors:  D Tidemalm; K Beckman; M Dahlin; M Vaez; P Lichtenstein; N Långström; B Runeson
Journal:  Psychol Med       Date:  2014-11-26       Impact factor: 7.723

6.  Examining the Impact of Suicide Attempt Function and Perceived Effectiveness in Predicting Reattempt for Emergency Medicine Patients.

Authors:  Stephen S O'Connor; Katherine Anne Comtois; David C Atkins; Amanda H Kerbrat
Journal:  Behav Ther       Date:  2016-05-25

7.  Risk Factors of a Suicide Reattempt by Seasonality and the Method of a Previous Suicide Attempt: A Cohort Study in a Japanese Primary Care Hospital.

Authors:  Minoru Sawa; Hiraki Koishikawa; Yoneatsu Osaki
Journal:  Suicide Life Threat Behav       Date:  2016-12-28

8.  Method of attempted suicide as predictor of subsequent successful suicide: national long term cohort study.

Authors:  Bo Runeson; Dag Tidemalm; Marie Dahlin; Paul Lichtenstein; Niklas Långström
Journal:  BMJ       Date:  2010-07-13

9.  Suicide and all-cause mortality following routine hospital management of self-harm: Propensity score analysis using multicentre cohort data.

Authors:  Sarah Steeg; Matthew Carr; Richard Emsley; Keith Hawton; Keith Waters; Harriet Bickley; Jennifer Ness; Galit Geulayov; Nav Kapur
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

10.  A prospective study of repetition of self-harm following deliberate self-poisoning in rural Sri Lanka.

Authors:  P H G J Pushpakumara; S U B Thennakoon; T N Rajapakse; Ranil Abeysinghe; A H Dawson
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.